The SINGLE INHALER THERAPY WITH SYMBICORT brand, founded in 2004 (Sweden), from 585 sister brands and 17478 competing brands. SINGLE INHALER THERAPY WITH SYMBICORT is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. SINGLE INHALER THERAPY WITH SYMBICORT is part of the Drug Manufacturers activity sector.

SINGLE INHALER THERAPY WITH SYMBICORT is a brand of ASTRAZENECA (AZN/L) News

ASTRAZENECA (SINGLE INHALER THERAPY WITH SYMBICORT) share price

Share price
Popularity of SINGLE INHALER THERAPY WITH SYMBICORT (ASTRAZENECA)

Popularity
Sustainability ASTRAZENECA

Sustainability
Other brands ASTRAZENECA

Other brands
Competing brands of SINGLE INHALER THERAPY WITH SYMBICORT

Rival brands
News

News

News from the brand SINGLE INHALER THERAPY WITH SYMBICORT

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Stock exchange: More information on ASTRAZENECA (SINGLE INHALER THERAPY WITH SYMBICORT)

SINGLE INHALER THERAPY WITH SYMBICORT is a brand of ASTRAZENECA (AZN/L) News

News from the brand SINGLE INHALER THERAPY WITH SYMBICORT

All news ASTRAZENECA (SINGLE INHALER THERAPY WITH SYMBICORT)

All news
ASTRAZENECA (SINGLE INHALER THERAPY WITH SYMBICORT)